Oklahoma researchers are studying how blocking sugar intake in heart cells could prevent diabetes-related heart failure and ...

The investigatory studies on blood were exempted from full review and approved by the Columbia University Institutional Review Board. Informed consent was obtained from the parents and patients who ...

The Tyrone community banded together for one child fighting a rare condition. At the Tyrone Alliance Church, 30 craft vendors ...

Many people living with diabetes don't even know their hearts are already under attack. But groundbreaking research hopes to ...

A deficiency in the protein responsible for moving glucose across the brain's protective blood-brain barrier appears to intensify the neurodegenerative effects of Alzheimer's disease, according to a ...

None — 12-year-old Remi Savioz was diagnosed with a rare neuro-metabolic brain disease called Glucose Transporter 1, which affects the amount of glucose that reaches the brain. She is one of only 200 ...

Novato, CA, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, ...

Ultragenyx Initiates New Development Program Studying Triheptanoin (UX007) for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) NOVATO, Calif., Aug 05, 2013 (GLOBE NEWSWIRE ...

University of Texas at Arlington. "Challenging the current approach to Glut1 deficiency." ScienceDaily. ScienceDaily, 24 April 2017. <www.sciencedaily.com / releases / 2017 / 04 / 170424141230.htm>.

METAglut1TM obtains universal national coverage by French National Health Insurance as of February 22, 2024 Nationwide, patients with suspected Glut1 deficiency syndrome will benefit from ...